N
Norimitsu Kadowaki
Researcher at Kagawa University
Publications - 185
Citations - 11069
Norimitsu Kadowaki is an academic researcher from Kagawa University. The author has contributed to research in topics: Cytotoxic T cell & Dendritic cell. The author has an hindex of 32, co-authored 167 publications receiving 10385 citations. Previous affiliations of Norimitsu Kadowaki include Teikyo University & Kyoto University.
Papers
More filters
Journal ArticleDOI
Syndrome of inappropriate antidiuretic hormone secretion induced by tacrolimus following allogeneic cord blood transplantation.
Yasuyuki Arai,Tadakazu Kondo,Toshiyuki Kitano,Kouhei Yamashita,Norimitsu Kadowaki,Akifumi Takaori-Kondo +5 more
TL;DR: The case of a 20-year-old man who developed SIADH three weeks after undergoing cord blood transplantation, and tacrolimus administration was suspected to be a cause of the disorder, it is believed that dose reduction, not discontinuation, is an effective strategy.
Journal ArticleDOI
Association of specific metastatic organs with the prognosis and chemotherapeutic response in patients with advanced lung cancer
TL;DR: Muscle and liver metastases were associated with poor outcomes and oncologists should select treatment strategies considering the patients' metastatic statuses as well as other clinical characteristics.
Journal ArticleDOI
Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab.
R. Wakiya,Tomohiro Kameda,Y. Takeuchi,H. Ozaki,Shusaku Nakashima,Hiromi Shimada,Norimitsu Kadowaki,Hiroaki Dobashi +7 more
TL;DR: During the patient’s clinical course, monitoring cytokine profiles, especially vascular endothelial growth factor, was useful in tracking the disease activity of TAFRO syndrome.
Journal ArticleDOI
Subacute Sensorimotor Neuropathy Accompanied by Anti-ganglioside GM1 Antibody in a Patient with Lung Cancer.
Nobuhiro Kanaji,Kodai Kume,Hitoshi Mizoguchi,Takuya Inoue,Naoki Watanabe,Noriko Nishiyama,Norimitsu Kadowaki,Tomoya Ishii +7 more
TL;DR: There is evidence that anti-ganglioside antibody inhibits tumor progression, prolonging the patient survival, however, severe neurological disturbance may offset the survival benefit of anti- Gangliosides antibody in patients with paraneoplastic neurological syndrome.
Journal ArticleDOI
Serum CYFRA 21-1 but not Vimentin is Associated with Poor Prognosis in Advanced Lung Cancer Patients
Nobuhiro Kanaji,Kyuichi Kadota,Akira Tadokoro,Takuya Inoue,Naoki Watanabe,Reiji Haba,Norimitsu Kadowaki,Tomoya Ishii +7 more
TL;DR: An elevated serum CYFRA 21-1 concentration was associated with shorter overall survival in advanced lung cancer patients, however, serum vimentin was not as useful as a tumor marker of lung cancer.